Item 5. Market for Registrant’s Common Equity
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is traded on NASDAQ under the symbol “OLLI.” The following tables set forth for the periods indicated the high and low sales prices of our common stock on NASDAQ.
2024
High
Low
First Quarter
$
84.38
$
68.05
Second Quarter
$
104.98
$
72.19
Third Quarter
$
102.38
$
86.05
Fourth Quarter
$
120.03
$
86.88
2023
High
Low
First Quarter
$
65.97
$
50.95
Second Quarter
$
73.71
$
52.93
Third Quarter
$
80.94
$
70.17
Fourth Quarter
$
83.19
$
68.57
As of February 1, 2025, we had approximately 177,325 stockholders of record.
Stock Performance Graph
The graph set forth below compares the cumulative stockholder return on our common stock between February 1, 2020 and February 1, 2025 to the cumulative return of (i) the NASDAQ Composite Total Return
index and (ii) the NASDAQ US Benchmark Retail Index over the same period. This graph assumes an initial investment of $100 on February 1, 2020 in our common stock, the NASDAQ Composite Total Return index and the NASDAQ US Benchmark Retail Index
and assumes the reinvestment of dividends, if any. Such returns are based on historical results and are not intended to suggest future performance.
2/1/20
1/30/21
1/29/22
1/28/23
2/3/24
2/1/25
Ollie’s Bargain Outlet Holdings, Inc.
100.00
178.60
84.71
101.75
141.53
210.24
NASDAQ Composite Total Return Index
100.00
175.59
106.29
82.88
80.43
88.30
NASDAQ US Benchmark Retail Index
100.00
137.26
142.67
120.56
161.79
215.52
38
Index
Dividends
Our common stock began trading on July 16, 2015. Since then, we have not declared any cash dividends nor do we expect to in the foreseeable future as we intend to retain our earnings to finance
the development and growth of our business and operations.
The Credit Facility contains a number of restrictive covenants that, among other things and subject to certain exceptions, restrict Ollie’s Bargain Outlet, Inc.’s and Ollie’s Holdings, Inc.’s (together the
“Borrowers”) ability and the ability of their subsidiaries to pay dividends on our capital stock or redeem, repurchase or retire our capital stock.
Securities Authorized for Issuance under Equity Compensation Plans
The information required by this Item will be set forth in the Proxy Statement and is incorporated herein by reference.
Information on Share Repurchases
Information regarding shares of common stock the Company repurchased during the thirteen weeks ended February 1, 2025 is as follows:
Period
Total number of
shares
repurchased (1)
Average
price paid
per share (2)
Total number of
shares purchased
as part of publicly
announced plans
or programs (3)
Approximate dollar
value of shares that
may yet be purchased
under the plans or
programs (3)
November 3, 2024 through November 30, 2024
—
—
—
$
38,395,894
December 1, 2024 through January 4, 2025
16,614
$
114.78
16,614
$
36,490,497
January 5, 2025 through February 1, 2025
35,541
$
108.06
35,541
$
32,646,530
Total
52,155
52,155
(1)
Consists of shares repurchased under the publicly announced share repurchase program.
(2)
Includes commissions for the shares repurchased under the share repurchase program.
(3)
On March 26, 2019, the Board of Directors of the Company authorized the repurchase of up to $100.0 million of shares of the Company’s common stock. This initial tranche expired on March 26, 2021. The
Board authorized the repurchase of another $100.0 million of the Company’s common stock on December 15, 2020, and a $100.0 million increase on March 16, 2021, resulting in $200.0 million approved for share repurchases through January 13,
2023. On November 30, 2021, the Board authorized an additional $200.0 million to repurchase stock pursuant to the Company’s share repurchase program, expiring on December 15, 2023. On November 30, 2023, the Company’s Board of Directors
authorized an extension to the existing share repurchase program set to expire on December 15, 2023, until March 31, 2026. Shares to be repurchased are subject to the same considerations regarding timing and amount of repurchases as the
initial authorization. As of February 1, 2025, the Company had approximately $32.7 million remaining under its share repurchase program. On March 19, 2025, the Company announced the Board of Directors approved a new share repurchase
authorization of an additional $300.0 million of the Company’s outstanding common stock; see further discussion in Note 14 “Subsequent Event” to our audited consolidated financial statements included elsewhere in this Annual Report on
Form 10-K. For further discussion on the share repurchase program, see “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital
Resources, Share Repurchase Program.”
39
Index
Item 6.
[Reserved]